Exact Mass: 385.0749430000001
Exact Mass Matches: 385.0749430000001
Found 191 metabolites which its exact mass value is equals to given mass value 385.0749430000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
S-Inosyl-L-homocysteine
L-homocysteine substituted at sulfur by a 5-deoxyinosin-5-yl group.
Tepoxalin
C20H20ClN3O3 (385.11931200000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].
chromopyrrolic acid
C22H15N3O4 (385.10625100000004)
A pyrroledicarboxylic acid that is pyrrole-2,5-dicarboxylic acid in which the hydrogens at positions 3 and 4 have been replaced by indol-3-yl groups.
Cefaclor hydrate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate
Sarafloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Sarafloxacin is used for control of Campylobacter infections in poultr It is used for control of Campylobacter infections in poultry
Niazicin
C17H23NO7S (385.11951680000004)
Niazicin is a glucosinolate and a naturally occurring thiocarbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans and cis rotamers of niazicin (niazicin A and niazicin B, respectively) differ in the orientation of the NH group with respect to sulfur. Constituent of Moringa oleifera (horseradish tree). Niazicin A is found in fats and oils, herbs and spices, and green vegetables.
Zeanoside C
Isolated from immature sweet corn kernels Zea mays (Gramineae). Zeanoside C is found in cereals and cereal products, fats and oils, and corn. Zeanoside A is found in cereals and cereal products. Zeanoside A is isolated from sweet corn kernels Zea mays (Gramineae).
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products.
Hydroxylansoprazole
C16H14F3N3O3S (385.0707930000001)
Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Lansoprazole sulfone
C16H14F3N3O3S (385.0707930000001)
Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake. The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.
Alizarin complexone
(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide
C20H19NO7 (385.11614640000005)
(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
C20H19NO7 (385.11614640000005)
Fleroxacin N-oxide
C17H18F3N3O4 (385.12493440000003)
Mavacoxib
C16H11F4N3O2S (385.05080740000005)
3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate
5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane
13-Methylberberine
C21H20ClNO4 (385.1080790000001)
13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3]. 13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3].
anisodamine
C17H24BrNO4 (385.08886040000004)
Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].
Sarafloxacin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3620 EAWAG_UCHEM_ID 3620; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1035
Azasetron HCl
C17H21Cl2N3O3 (385.09598960000005)
Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
(2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside
Zeanoside C
BIOTIN 4-AMIDOBENZOIC ACID SODIUM SALT
C17H20N3NaO4S (385.1072160000001)
6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
C20H19NO3S2 (385.0806304000001)
6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
2,3-dimethylnaphtho[1,2-d]thiazolium tosylate
C20H19NO3S2 (385.0806304000001)
tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate
C17H24BrNO4 (385.08886040000004)
Bis(ethylenediamine)platinum(II) chloride
C4H16Cl2N4Pt (385.03998060000004)
ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate
C16H17Cl2N3O2S (385.04184820000006)
BRL 37344, sodium salt
C19H21ClNNaO4 (385.1056736000001)
BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1].
(2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid
C17H23NO7S (385.11951680000004)
4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID
C22H15N3O4 (385.10625100000004)
3(4-DIMETHYLAMINO-1-NAPHTHYLAZO)-4-METHOXYBENZENESULFONIC ACID
C19H19N3O4S (385.10962140000004)
[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate
1H-1,2,4-triazole-5-carboxylic acid
C15H19N3O9 (385.11212439999997)
tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate
C17H24BrNO4 (385.08886040000004)
L-ASPARTIC ACID BIS-ALLYL ESTER P-TOLUENESULFONATE SALT
C17H23NO7S (385.11951680000004)
Denibulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
2-[ethyl[3-methyl-4-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl]amino]ethanol
5-bromo-6-chloro-3-indoxyl nonanoate
C17H21BrClNO2 (385.04440960000005)
AMMONIUM PENTABORATE TETRAHYDRATE
B5H12NO19-------------- (385.04687920000003)
YS-49
C20H20BrNO2 (385.06773200000003)
YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].
5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER
N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de
2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid
C16H14F3N3O3S (385.0707930000001)
(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate
C20H16ClNO5 (385.07169560000006)
N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea
C15H17F6N3S (385.10473140000005)
Azasetron
C17H20ClN3O3·HCl (385.09598960000005)
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].
ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate
ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate
(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)
C20H19NO7 (385.11614640000005)
Ciprofloxacin Hydrochloride
C17H21ClFN3O4 (385.12045480000006)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].
(5-bromo-4-chloro-1H-indol-3-yl) nonanoate
C17H21BrClNO2 (385.04440960000005)
4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide
C15H20BrN3O2S (385.04595200000006)
tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate
Mavacoxib
C16H11F4N3O2S (385.05080740000005)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylic acid
C17H18F3N3O4 (385.12493440000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione
C22H15N3O4 (385.10625100000004)
(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone
ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate
C16H11F4N3O2S (385.05080740000005)
Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate
C19H16ClN3O2S (385.06517060000004)
2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester
C20H19NO5S (385.0983884000001)
2-phenyl-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-4-quinolinecarboxamide
C23H19N3OS (385.12487640000006)
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide
2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide
C21H17ClFNO3 (385.08809340000005)
Omeprazole sodium hydrate
C17H20N3NaO4S (385.1072160000001)
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
Phosphatidyl-L-serine
[4,5-Dihydroxy-6-[4-[(methoxycarbothioylamino)methyl]phenoxy]-2-methyloxan-3-yl] acetate
C17H23NO7S (385.11951680000004)
(2R)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol
[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate
(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate
(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide
(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester
Benzylidenehydrazine derivative, 12
C15H20BrN3O4 (385.06371000000007)
4-[4-[(2-Oxo-1,3-dihydroindol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde
C19H19N3O4S (385.10962140000004)
(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione
C18H15N3O3S2 (385.05548000000005)
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide
C20H19NO5S (385.0983884000001)
Versicolorone(1-)
An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.
4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide
(2S)-versicolorone(1-)
An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.
3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide
C15H16ClN3O3S2 (385.03215759999995)
vittatine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
(S)-5-oxoaverantin(1-)
A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide
4,5-Dimethyl-2-[[1-oxo-2-(4-quinazolinyloxy)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester
C19H19N3O4S (385.10962140000004)
N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide
C17H15BrF3NO (385.02890360000004)
N-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide
C19H19N3O4S (385.10962140000004)
8-O-demethyloxomaritidine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
ethyl 1-[(4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]piperidine-4-carboxylate
C19H19N3O4S (385.10962140000004)
4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
C20H19NO5S (385.0983884000001)
2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide
2-[[3-[4-(Dimethylamino)phenyl]-4,5-dihydroisoxazol-5-yl]methyl]-1,1-dioxo-1,2-benzothiazol-3-one
C19H19N3O4S (385.10962140000004)
2-[[4-(3-Methoxyphenyl)-5-[(4-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetic acid
C19H19N3O4S (385.10962140000004)
1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide
4-[oxo-(4-oxo-5H-thieno[3,2-c]quinolin-2-yl)methyl]-1-piperazinecarboxylic acid ethyl ester
C19H19N3O4S (385.10962140000004)
1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide
C19H19N3O2S2 (385.09186339999997)
4-methyl-2-[3-methyl-4-(3-methylphenyl)azo-5-oxo-4H-pyrazol-1-yl]-5-thiazolecarboxylic acid ethyl ester
3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide
C19H16ClN3O2S (385.06517060000004)
[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate
N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide
C19H16ClN3O4 (385.08292860000006)
epivittatine Trifluoroacetic acid
A natural product found in Crinum asiaticum var. sinicum.
[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
2-Amino-3-[(2-butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
TEPOXALIN
C20H20ClN3O3 (385.11931200000004)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Tepoxalin is a dual inhibitor of COX and 5-lipoxygenase (5-LO) with potent anti-inflammatory activity and a favorable gastrointestinal profile[1].
3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid
C22H15N3O4 (385.10625100000004)
S-inosyl-L-homocysteine zwitterion
Zwitterionic form of S-inosyl-L-homocysteine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
KJ Pyr 9
C22H15N3O4 (385.10625100000004)
KJ Pyr 9 is an inhibitor of MYC with a Kd of 6.5 nM in in vitro assay.
SKI-349
C19H19N3O4S (385.10962140000004)
SKI-349 is a dual-targeted inhibitor of sphingosine kinase 1/2 (SPHK1/2) and microtubule assembly (MDA). SKI-349 has anticancer activity. SKI-349 can inhibit the vitality, invasion, and AKT/mTOR signaling pathway of liver cells[1][2].
5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
(2s)-2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid
[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid
aristolochicacid iva methyl ester
{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid
1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one
C20H19NO7 (385.11614640000005)
3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid
C20H19NO7 (385.11614640000005)
3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanamide
C14H20BrN5O3 (385.0749430000001)
(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one
C20H19NO7 (385.11614640000005)
(2r,3s,4r,5r,6r)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)
4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)
2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid
1-chloro-n-{2-chloro-2-[4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride
(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid
C20H19NO7 (385.11614640000005)
methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate
C20H19NO7 (385.11614640000005)
(2e)-3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanimidic acid
C14H20BrN5O3 (385.0749430000001)
methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate
C20H19NO7 (385.11614640000005)
5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid
C20H19NO7 (385.11614640000005)
(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid
(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[4-({[methoxy(sulfanyl)methylidene]amino}methyl)phenoxy]-2-methyloxan-3-yl acetate
C17H23NO7S (385.11951680000004)